Christine Blank

662 total citations
30 papers, 553 citations indexed

About

Christine Blank is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Geriatrics and Gerontology. According to data from OpenAlex, Christine Blank has authored 30 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 8 papers in Immunology and 4 papers in Geriatrics and Gerontology. Recurrent topics in Christine Blank's work include Research on Leishmaniasis Studies (9 papers), Pharmaceutical Economics and Policy (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Christine Blank is often cited by papers focused on Research on Leishmaniasis Studies (9 papers), Pharmaceutical Economics and Policy (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Christine Blank collaborates with scholars based in Germany and Switzerland. Christine Blank's co-authors include Heidrun Moll, Martin Röllinghoff, Klaus J. Erb, Uwe Ritter, Stefanie B. Flohé, Christian Bogdan and Horst Bluethmann and has published in prestigious journals such as The Journal of Infectious Diseases, European Journal of Immunology and Advances in experimental medicine and biology.

In The Last Decade

Christine Blank

27 papers receiving 542 citations

Peers

Christine Blank

IMMUN

PHEOH

EPIDE

PARAS

RHEUM

Shikha Shrivastava India

Soombul Zubairi United Kingdom

Norma Salaiza Mexico

G. Càceres‐Dittmar Venezuela

Daniela Faria Brazil

June Hariprashad United States

Jiaxiang Ji United States

Shafrira Shai Israel

Jacob T. Minang Sweden

Farrukh S. Rizvi France

Shikha Shrivastava India

Christine Blank

154 ×0.5

IMMUN

197 ×0.6

PHEOH

256 ×1.7

EPIDE

45 ×0.7

PARAS

26 ×0.5

RHEUM

Citations per year, relative to Christine Blank Christine Blank (= 1×) peers Shikha Shrivastava

Countries citing papers authored by Christine Blank

Since Specialization

Citations

This map shows the geographic impact of Christine Blank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Blank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Blank more than expected).

Fields of papers citing papers by Christine Blank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Blank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Blank. The network helps show where Christine Blank may publish in the future.

Co-authorship network of co-authors of Christine Blank

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Blank. A scholar is included among the top collaborators of Christine Blank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Blank. Christine Blank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Blank, Christine. (2020). Pharmacy Chains, Other Retailers to Offer COVID-19 Testing. 1 indexed citations

2.

Blank, Christine. (2016). FDA approves first drug for Duchenne muscular dystrophy. 5 indexed citations

3.

Blank, Christine. (2016). To sell or not to sell tobacco: Who should decide?. 1 indexed citations

4.

Blank, Christine. (2016). Top 7 new facts about drug spending.

5.

Blank, Christine. (2016). Synchronized meds boost patient adherence, pharmacy efficiency. 2 indexed citations

6.

Blank, Christine. (2015). Meijer opens pharmacy in Michigan hospital. 1 indexed citations

7.

Blank, Christine. (2015). How pharmacists can keep up with biosimilar approvals.

8.

Blank, Christine. (2015). FDA approves new heart failure drug. 1 indexed citations

9.

Blank, Christine. (2015). FDA approves drug to treat rare bile acid synthesis disorders in kids, adults. 2 indexed citations

10.

Blank, Christine. (2015). N.Y. hospital retail pharmacy aims to cut readmission rates. 1 indexed citations

11.

Blank, Christine. (2015). CMS RELEASES MEDICARE PART D PHYSICIAN PRESCRIBING DATA.. PubMed. 92(10). 53–53. 1 indexed citations

12.

Blank, Christine. (2012). Minn. ACO uses MTM to reduce hospital readmissions. 1 indexed citations

13.

Blank, Christine, et al.. (1996). Murine epidermal Langerhans cells do not express inducible nitric oxide synthase. European Journal of Immunology. 26(4). 792–796. 28 indexed citations

14.

Moll, Heidrun, et al.. (1996). Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells. Medical Microbiology and Immunology. 184(4). 163–168. 13 indexed citations

15.

Erb, Klaus J., Christine Blank, & Heidrun Moll. (1996). Susceptibility to Leishmania major in IL‐4 transgenic mice is not correlated with the lack of a Th1 immune response. Immunology and Cell Biology. 74(3). 239–244. 18 indexed citations

16.

Erb, Klaus J., Christine Blank, Uwe Ritter, Horst Bluethmann, & Heidrun Moll. (1996). Leishmania Major Infection in Major Histocompatibility Complex Class II-Deficient Mice: CD8+ T Cells Do not Mediate a Protective Immune Response. Immunobiology. 195(2). 243–260. 32 indexed citations

17.

Moll, Heidrun, Stefanie B. Flohé, & Christine Blank. (1995). Dendritic Cells Seclude Leishmania Parasites that Persist in Cured Mice — A Role in the Maintenance of T-Cell Memory?. Advances in experimental medicine and biology. 378. 507–509. 16 indexed citations

18.

Moll, Heidrun, et al.. (1993). Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cells. European Journal of Immunology. 23(7). 1595–1601. 228 indexed citations

19.

Blank, Christine, et al.. (1993). Parasitism of Epidermal Langerhans Cells in Experimental Cutaneous Leishmaniasis withLeishmania major. The Journal of Infectious Diseases. 167(2). 418–425. 137 indexed citations

20.

Blank, Christine, et al.. (1992). Murine epidermal Langerhans cells are potent stimulators of an antigen‐specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. European Journal of Immunology. 22(6). 1341–1347. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact